<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Laboratory Journal</title>
<title_fa>Medical Laboratory Journal</title_fa>
<short_title>mljgoums</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mlj.goums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2538-4449</journal_id_issn>
<journal_id_issn_online>2538-4449</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61186/mlj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>6</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Anti-SARS-CoV-2 IgG Response after First and Second Dose of COVID-19 Vaccine</title>
	<subject_fa>ایمنی شناسی</subject_fa>
	<subject>Immunology</subject>
	<content_type_fa>تحقيقي</content_type_fa>
	<content_type>Original Paper</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-size:12px;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;&lt;span style=&quot;font-weight:bold&quot;&gt;&lt;span style=&quot;line-height:200%&quot;&gt;Background:&lt;span style=&quot;font-weight:normal&quot;&gt; Pandemics have serious adverse impacts on public health, economy, social structure, and overall growth and development of a nation. Such impacts can be mitigated by timely introduction of effective vaccination programs. This was successfully achieved in India. This study was performed to compare the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) responses after first and second dose of coronavirus disease 2019 (COVID-19) vaccination.&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span style=&quot;font-weight:normal&quot;&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span calibri=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Methods:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;This cross-sectional study included 60 people who were vaccinated with the AstraZeneca vaccine at Karnataka Institute of Medical Sciences, Hubballi, India. The subjects were divided into two groups. Group I included 30 people who had received a single dose of the vaccine, and group II included 30 people who had received two doses of the vaccine. Exclusion criteria included having a history of influenza like illness/severe acute respiratory infection/proven COVID-19 infection in past 6 months. The antibody response was measured by the Anti-SARS-CoV-2 IgG test using the VITROS Anti-SARS-CoV-2 IgG Reagent Pack.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span calibri=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Results: &lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;We observed that&lt;b&gt; &lt;/b&gt;97% of the subjects had reactive IgG antibodies after receiving two doses of the vaccine, whereas only 83% of the subjects developed antibodies after a single dose of the vaccine. A positive correlation was observed between the development of reactive antibodies and the duration between the first dose and the second dose (r=0.24). &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span calibri=&quot;&quot;&gt;&lt;b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Conclusion:&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;b&gt; &lt;/b&gt;&lt;span style=&quot;line-height:200%&quot;&gt;&lt;span new=&quot;&quot; roman=&quot;&quot; times=&quot;&quot;&gt;Based on the results,&lt;b&gt; &lt;/b&gt;the two-dose vaccination with the AstraZeneca vaccine is beneficial over the single-dose vaccination for protection against COVID-19. Moreover, increasing the duration between doses might improve the antibody response. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>COVID-19,COVID-19 Vaccines,Pandemics,</keyword>
	<start_page>40</start_page>
	<end_page>44</end_page>
	<web_url>http://mlj.goums.ac.ir/browse.php?a_code=A-10-1237-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Muragendraswami</first_name>
	<middle_name></middle_name>
	<last_name>Astagimath</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>astagimath@gmail.com</email>
	<code>100319475328460032053</code>
	<orcid>100319475328460032053</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biochemistry, Karnataka Institute of Medical Sciences, Hubballi, Karnataka, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Suman</first_name>
	<middle_name></middle_name>
	<last_name>Doddamani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>suman_medico4@yahoo.co.in</email>
	<code>100319475328460032054</code>
	<orcid>100319475328460032054</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Biochemistry, Karnataka Institute of Medical Sciences, Hubballi Karnataka, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Vishwanath</first_name>
	<middle_name></middle_name>
	<last_name>Patil</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>vcpatil2009@gmail.com</email>
	<code>100319475328460032055</code>
	<orcid>100319475328460032055</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Assistant Professor,Department of General Medicine, Karnataka Institute of medical sciences, Hubballi, Karnataka, India.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Raviraja</first_name>
	<middle_name></middle_name>
	<last_name>Aryapu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>raviraj.po@gmail.com</email>
	<code>100319475328460032056</code>
	<orcid>100319475328460032056</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of General Medicine, Karnataka Institute of medical sciences, Hubballi, Karnataka, India  </affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
